TITLE

Lopinavir/ritonavir

PUB. DATE
November 2014
SOURCE
Reactions Weekly;Nov2014, Vol. 1528 Issue 1, p137
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents case studies of two HIV-infected patients who developed symptomatic grade III hepatotoxicity after receiving double-dose lopinavir/ ritonavir tablets for at least 2 months.
ACCESSION #
99566733

 

Related Articles

  • Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease. Casado, José L.; Del Palacio, María; Moya, Javier; Rodriguez, José M.; Moreno, Ana; Perez-Elías, María J.; Belso, Ana; Dronda, Fernando; Moreno, Santiago // HIV Clinical Trials;Sep/Oct2011, Vol. 12 Issue 5, p235 

    Purpose: There are few data about the safety and pharmacokinetics of lopinavir in HIV/HCV coinfected patients with very advanced liver disease.Method: Prospective study of 60 HIV/HCV coinfected patients who underwent a liver biopsy and received a lopinavir-based regimen. The rate of...

  • Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients. Macías, Juan; Neukam, Karin; Mallolas, Josep; López-Cortés, Luis F.; Cartón, José A.; Domingo, Pere; Moreno, Santiago; Iribarren, José A.; Clotet, Bonaventura; Crespo, Manell; de Los Santos, Ignacio; Ortega, Enrique; Knobel, Hernando; Jiménez-Expósito, María J.; Pineda, Juan A.; on behalf of the COINS Study Team*, Juan // HIV Clinical Trials;Mar/Apr2012, Vol. 13 Issue 2, p61 

    Objective: To evaluate the incidence and risk factors for grade 3 or 4 ALT or AST elevations (TE) and grade 4 total bilirubin elevations (TBE) among HIV/HCV- coinfected treatment-naïve patients with an initial regimen including 2 nucleoside analogs plus efavirenz (EFV), nevirapine (NVP), or a...

  • Antiretrovirals/gemfibrozil/rosuvastatin interaction.  // Reactions Weekly;8/13/2011, Issue 1364, p8 

    The article describes the case of an eldery man who developed rhabdomyolysis during treatment with lopinavir/ritonavir and tenofovir for HIV infection and gemfibrozil and rosuvastatin for dyslipidemia.

  • Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers. Jackson, A. G. A.; Hill, A.; Else, L. J.; Back, D. J.; Morley, R.; Puls, R.; Amin, J.; Lin, E.; Boffito, M. // Journal of the International AIDS Society;2010 Supplement 4, Vol. 13 Issue Suppl 4, p1 

    An abstract of the article "Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers," by several authors including AGA Jackson, A Hill, and DJ Back is presented.

  • Minority M184V variants in women exposed to 3TC/FTC-containing lopinavir-ritonavir (LPVr) regimens in pregnancy. Surah, S.; Oshea, S.; Costelloe, S.; Hanlon, M.; Mullen, J.; Chrystie, I.; Taylor, G. P.; De Ruiter, A. // Journal of the International AIDS Society;2010 Supplement 4, Vol. 13 Issue Suppl 4, p1 

    An abstract of the article "Minority M184V variants in women exposed to 3TC/FTC-containing lopinavir-ritonavir (LPVr) regimens in pregnancy," by several authors including GP Taylor, M Douglas, and J Smith is presented.

  • Lacidipine/lopinavir/ritonavir/metoprolol interaction.  // Reactions Weekly;4/16/2011, Issue 1347, p26 

    The article describes the case of a 51-year-old man who developed bradycardia, hypotension and complete antrioventricular (AV) block while being treated with lacidipine, lopinavir, ritonavir and metoprolol.

  • Orlistat/lopinavir/ritonavir interaction.  // Reactions Weekly;5/7/2011, Issue 1350, p36 

    The article describes the case of a 39-year-old woman with HIV-1 infection who experienced decreased cerebrospinal fluid (CSF) lopinavir concentrations, leading to HIV-related meningo-encephalitis, during highly active anti-retroviral therapy (HAART) with lopinavir/ritonavir in addition to...

  • Efavirenz interaction.  // Reactions Weekly;8/26/2006, Issue 1116, p13 

    The article describes the case of a 37-year-old man with acute HIV infection who developed increased serum efavirenz concentrations after receiving efavirenz and decreased plasma lopinavir concentration following an interaction with concomitant lopinavir.

  • Lopinavir/ritonavir.  // Reactions Weekly;8/13/2011, Issue 1364, p31 

    The article describes three cases of premature infants who developed adrenal insufficiency after receiving treatment with lopinavir/ritonavir.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics